At CD Formulation, we excel in crafting targeted drug delivery systems that ensure precise and efficient transport of compounds to specified locations. Our advanced technologies and creative methodologies are tailored to meet the diverse needs of our clients, optimizing functionality and effectiveness.
TDDS aims to deliver drugs directly to specific sites within the body, using carriers to target particular organs or cells, ensuring prolonged presence and effectiveness. It features precise delivery, accumulation, regulated release, and compatibility with biological systems. The system can employ unique molecular tags for active delivery straight to cell targets, optimizing effectiveness while minimizing unwanted effects.
Fig.1 Advantages of targeted drug delivery systems. (CD Formulation)
Fig.2 Schematic of different types of carriers. (CD Formulation)
Items | Descriptions |
---|---|
Polymer Carriers | Synthetic or natural polymers such as PLGA and chitosan can be chemically modified for improved binding and protection of nucleic acids. |
Dendrimers | Highly branched molecules capable of electrostatically or covalently bonding with nucleic acids, offering excellent cellular penetration. |
Inorganic Nanomaterials | Such as gold nanoparticles and silica nanoparticles, which can be modified to enhance stability and targeting. |
Protein/Peptide Carriers | Use specific proteins or peptide sequences to bind with nucleic acids, enhancing cellular uptake. |
Viral Vectors | Use modified viruses like adenoviruses and lentiviruses to deliver nucleic acids, offering high efficiency. |
PEGylation is a crucial method for achieving long circulation and targeting. In delivery carriers, both targeting molecules and PEG may coexist, linked in various ways to provide long-circulating and targeting properties.
Common carriers include micro-particles such as liposomes, emulsions, nanoparticles, or nanocapsules, each changing drug distribution and enhancing bioavailability, formulation uniformity, dispersibility, and absorption.
Utilizing peptides, monoclonal antibodies, and their fragments as targeting vehicles by covalent coupling or adsorption onto drug carriers, or forming conjugates with cytotoxic molecules, aims to selectively exert anti-tumor effects while minimizing normal tissue toxicity.
Fig.3 Flow chart of targeted drug delivery system design. (CD Formulation)
Our nucleic acid drug delivery platform, by offering advanced carrier technologies, has significantly advanced the development of targeted drug delivery systems. Our platform can be utilized to design efficient delivery mechanisms, ensuring that nucleic acid drugs precisely reach their target areas.
Technology: Development of Nanocarriers for Targeted Drug Delivery Systems
Journal: Journal of Drug Delivery Science and Technology
IF: 4.5
Published: 2021
Results:
Targeted drug delivery enhances medication precision by using nanoparticles and nanoscale materials, favored for their optimal size and loading capabilities, to focus treatment on specific areas. Nanodelivery systems have the potential to traverse the blood-brain barrier, offering new opportunities for brain-targeted therapies. Furthermore, nanocarriers with conjugated drugs can optimize drug distribution and sustain circulation. This overview highlights the importance of nanocarriers in enhancing therapeutic outcomes.
Fig.4 Nanocarriers for targeted drug delivery. (Shah A, et al., 2021)
CD Formulation offers support and consultation throughout initial design and subsequent development stages to optimize delivery system efficiency and performance. If interested in our targeted drug delivery system design services, please feel free to contact us.
References